References
- TorchilinVPTargeted pharmaceutical nanocarriers for cancer therapy and imagingAAPS J200792E128E14717614355
- DilnawazFSinghAMohantyCSahooSKDual drug loaded super-paramagnetic iron oxide nanoparticles for targeted cancer therapyBiomaterials201031133694370620144478
- De JongWHBormPJDrug delivery and nanoparticles:applications and hazardsInt J Nanomedicine20083213314918686775
- ChomouckaJDrbohlavovaJHuskaDAdamVKizekRHubalekJMagnetic nanoparticles and targeted drug deliveringPharmacol Res201062214414920149874
- GuedesMHASadeghianiNPeixotoDLGEffects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice peritoneal cellsJof Magn Magn Mater20052931283286
- PortilhoFAEstevanatoLLCMiranda-VilelaALInvestigation of a magnetohyperthermia system efficacyJ App Phys20101097B307B309
- MurthySKNanoparticles in modern medicine: state of the art and future challengesInt J Nanomedicine20072212914117722542
- McBainSCYiuHHDobsonJMagnetic nanoparticles for gene and drug deliveryInt J Nanomedicine20083216918018686777
- GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials200526183995402115626447
- MornetSVasseurSGrassetFMagnetic nanoparticle design for medical applicationsProgr Solid State Chem2006342–4237247
- LacavaLMGarciaVAPKückelhausSLong-term retention of dextran-coated magnetite nanoparticles in the liver and spleenJ Magn Magn Mater2004272–276Pt 324342435
- KratzFAlbumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
- LiJ-mChenWWangHPreparation of albumin nanospheres loaded with gemcitabine and their cytotoxicity against BXPC-3 cells in vitroActa Pharmacol Sin20093091337134319730429
- MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancerInt J Nanomedicine200949910519516888
- SimioniARRodriguesMMAPrimoFLMoraisPCTedescoACEffect of diode-laser and AC magnetic field of bovine serum albumin nanospheres loaded with phthalocyanine and magnetic particlesJ Nanosci Nanotechnol20111143604360821776743
- FigueiredoLCLacavaBMSkeff NetoKPelegriniFMoraisPCMagnetic resonance study of maghemite-based magnetic fluidJ Magn Magn Mater200832014e347e350
- SimioniARMartinsOPLacavaZGCell toxicity studies of albumin-based nanosized magnetic beadsJ Nanosci Nanotechnol2006682413241517037849
- MoraisPCGargVKOliveiraACSynthesis and characterization of size-controlled cobalt-ferrite-based ionic ferrofluidsJ Magn Magn Mater20012251–23740
- FreitasMLLSilvaLPAzevedoRBA double-coated magnetite-based magnetic fluid evaluation by cytometry and genetic testsJ Magn Magn Mater2002252396398
- KückelhausSReisSCCarneiroMFIn vivo investigation of cobalt ferrite-based magnetic fluid and magnetoliposomes using morphological testsJ Magn Magn Mater2004272–276Pt 324022403
- LaquintanaVTrapaniADenoraNWangFGalloJMTrapaniGNew strategies to deliver anticancer drugs to brain tumorsExpert Opin Drug Deliv20096101017103219732031
- DobrovolskaiaMAMcNeilSEImmunological properties of engineered nanomaterialsNat Nanotechnol20072846947818654343
- JainTKReddyMKMoralesMALeslie-PeleckyDLLabhasetwarVBiodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in ratsMol Pharm20085231632718217714
- LacavaZGMTedescoACAzevedoRBMoraisPCThe use of magnetic nanoparticles in drug-delivery systems: the interaction of nanoparticles with cellsKumarMNVHandbook of Particulate Drug DeliveryCaliforniaAmerican Scientific Publishers2008223233
- OgawaraKFurumotoKNagayamaSPre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticlesJ Control Release2004100345145515567509
- LerouxJCDe JaeghereFAnnerBDoelkerEGurnyRAn investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D,L-lactic acid) nanoparticles by human monocytesLife Sci19955776957037637541
- ChellatFMerhiYMoreauAYahiaLTherapeutic potential of nanoparticulate systems for macrophage targetingBiomaterials200526357260727516023200
- OwensDEPeppasNAOpsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInt J Pharm200630719310216303268
- VonarbourgAPassiraniCSaulnierPBenoitJPParameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials200627244356437316650890
- LacavaZGMAzevedoRBLacavaLMToxic effects of ionic magnetic fluids in miceJ Magn Magn Mater19991941–39095
- GarciaMPParcaRMChavesSBMorphological analysis of mouse lungs after treatment with magnetite-based magnetic fluid stabilized with DMSAJ Magn Magn Mater20052931277282
- SadeghianiNBarbosaLSGuedesMHAMagnetic resonance of polyaspartic acid-coated magnetite nanoparticles administered in miceIEEE Trans Magn2005411041084110
- PremkumarKBowlusCLAscorbic acid reduces the frequency of iron induced micronuclei in bone marrow cells of miceMutat Res20035421–29910314644358
- CintraDOSEstevanatoLLCSimioniARSuccessful strategy for targeting the central nervous system using magnetic albumin nanospheresJ Biomed Nanotechnol In press2011
- BickelUYoshikawaTPardridgeWMDelivery of peptides and proteins through the blood-brain barrierAdv Drug Deliv Rev2001461–324727911259843
- TholeMNobmannSHuwylerJBartmannAFrickerGUptake of cationzied albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillariesJ Drug Target200210433734412164382
- LuWTanYZHuKLJiangXGCationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrierInt J Pharm20052951–224726015848009
- YangHNanoparticle-Mediated Brain-Specific Drug Delivery, Imaging, and DiagnosisPharm Res20102791759177120593303
- VogelSMMinshallRDPilipovicMTiruppathiCMalikABAlbumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding proteinAm J Physiol Lung Cell Mol Physiol20012816L1512L152211704548
- SimioniARPrimoFLRodriguesMMALacavaZGMMoraisPCTedescoACPreparation, characterization and in vitro toxicity test of magnetic nanoparticle-beads drug delivery system to hyperthermia of biological tissuesIEEE Trans Magn200743624592461
- MisraAGaneshSShahiwalaAShahSPDrug delivery to the central nervous system: a reviewJ Pharm Pharm Sci20036225227312935438
- HuY-LGaoJ-QPotential neurotoxicity of nanoparticlesInt J Pharm20103941–211512120433914
- LockmanPRKoziaraJRoderKEIn vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticlesPharm Res200320570571312751624
- SuwalskyMMartínezFCárdenasHGrzybJStrzalkaKIron affects the structure of cell membrane molecular modelsChem Phys Lipids20051341697715752465
- OhbaSHiramatsuMEdamatsuRMoriIMoriAMetal ions affect neuronal membrane fluidity of rat cerebral cortexNeurochem Res19941932372418177364
- BanatiRBNeuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brainBr Med Bull200365112113112697620
- SastrySArendashGWTime-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complexNeuroscience19956736496667545796
- NaqviSSamimMAbdinMZConcentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stressInt J Nanomedicine2010598398921187917
- Van KasterenSICampbellSJSerresSAnthonyDCSibsonNRDavisBGGlyconanoparticles allow pre-symptomatic in vivo imaging of brain diseaseProc Natl Acad Sci U S A20091061182319106304